QIM
Quantitative Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,565
| Closed | -$1.12M | – | 253 |
|
|
2023
Q4 | $1.12M | Buy |
+11,565
| New | +$1.12M | 0.06% | 246 |
|
|
2023
Q1 | – | Sell |
-23,163
| Closed | -$2.4M | – | 232 |
|
|
2022
Q4 | $2.4M | Buy |
23,163
+18,854
| +438% | +$1.95M | 0.46% | 48 |
|
|
2022
Q3 | $365K | Buy |
+4,309
| New | +$365K | 0.06% | 217 |
|
|
2022
Q1 | – | Sell |
-5,846
| Closed | -$516K | – | 209 |
|
|
2021
Q4 | $516K | Buy |
+5,846
| New | +$516K | 0.07% | 175 |
|
|
2021
Q3 | – | Sell |
-22,070
| Closed | -$1.84M | – | 399 |
|
|
2021
Q2 | $1.84M | Buy |
+22,070
| New | +$1.84M | 0.17% | 133 |
|
|
2021
Q1 | – | Sell |
-25,775
| Closed | -$2.26M | – | 507 |
|
|
2020
Q4 | $2.26M | Buy |
+25,775
| New | +$2.26M | 0.18% | 133 |
|
|
2017
Q4 | – | Sell |
-15,800
| Closed | -$1.47M | – | 756 |
|
|
2017
Q3 | $1.47M | Buy |
15,800
+2,000
| +14% | +$186K | 0.02% | 538 |
|
|
2017
Q2 | $1.25M | Buy |
+13,800
| New | +$1.25M | 0.02% | 559 |
|
|
2016
Q2 | – | Sell |
-28,900
| Closed | -$2.38M | – | 749 |
|
|
2016
Q1 | $2.38M | Buy |
+28,900
| New | +$2.38M | 0.12% | 220 |
|
|
2015
Q3 | – | Sell |
-4,900
| Closed | -$670K | – | 686 |
|
|
2015
Q2 | $670K | Buy |
+4,900
| New | +$670K | 0.1% | 186 |
|
|
2015
Q1 | – | Sell |
-4,900
| Closed | -$442K | – | 626 |
|
|
2014
Q4 | $442K | Sell |
4,900
-1,800
| -27% | -$162K | 0.07% | 288 |
|
|
2014
Q3 | $483K | Buy |
+6,700
| New | +$483K | 0.09% | 181 |
|
|
2014
Q2 | – | Sell |
-50,600
| Closed | -$3.45M | – | 470 |
|
|
2014
Q1 | $3.45M | Buy |
+50,600
| New | +$3.45M | 0.16% | 87 |
|
|
2013
Q4 | – | Sell |
-39,300
| Closed | -$2.84M | – | 574 |
|
|
2013
Q3 | $2.84M | Buy |
+39,300
| New | +$2.84M | 0.25% | 78 |
|